Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary and secondary stroke prevention

W M Feinberg1

  • 1Department of Neurology, University of Arizona Health Sciences Center, Tucson 85724, USA.

Current Opinion in Neurology
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time course of platelet activation following acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.

Stroke·1999
Same author

Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

Thrombosis and haemostasis·1999
Same author

Clinically significant differences in the International Normalized Ratio measured with reagents of different sensitivities. SPAF Investigators. Stroke Prevention in Atrial Fibrillation.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1999
Same author

Stroke risk in an elderly population with atrial fibrillation.

Journal of general internal medicine·1999
Same author

Anticoagulation for prevention of stroke.

Neurology·1998
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Preventing stroke is achievable through targeted medical and surgical treatments. Clinical trials confirm the effectiveness of managing risk factors, antiplatelet and anticoagulant therapies, and carotid endarterectomy for stroke prevention.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Preventive Medicine

Background:

  • Stroke remains a leading cause of disability and death worldwide.
  • Advances in clinical trials offer new insights into stroke prevention strategies.
  • Effective interventions require precise application based on patient-specific risk factors.

Purpose of the Study:

  • To review current clinical trial evidence for stroke prevention therapies.
  • To identify areas where treatment guidelines are well-established.
  • To highlight remaining uncertainties in stroke prevention.

Main Methods:

  • Systematic review of recent clinical trials on stroke prevention.
  • Analysis of data on medical therapies (risk factor management, antiplatelet, anticoagulant).

Related Experiment Videos

  • Evaluation of surgical interventions, specifically carotid endarterectomy.

    • Main Results:

    • Clinical trials demonstrate efficacy of risk factor modification in preventing stroke.
    • Antiplatelet and anticoagulant therapies are proven effective under specific conditions.
    • Carotid endarterectomy shows benefit in select patient populations for stroke prevention.

    Conclusions:

    • Stroke prevention is feasible with evidence-based medical and surgical interventions.
    • Application of therapies must be tailored to individual clinical circumstances.
    • Further research is needed to address remaining uncertainties in stroke prevention strategies.